THEMIS-PCI: Potent Dual Antiplatelet Regimen Found Beneficial in Diabetic Patients with CAD and History of PCI

For Stroke Prevention in Patients with Atrial Fibrillation Undergoing PCI, Double Antiplatelet Therapy Found to be Safe

Landmark DAPA-HF Trial: New Approach to Treatment of Heart Failure

Clarifying the Heart Failure Story: Data from PARAGON-HF, EVALUATE-HF, and PROVE-HF

SGLT-2 Inhibitor Decreases Renal Outcomes in Diabetic Patients without Baseline Renal Impairment

DECLARE-TIMI 58 Sub-analyses: Expanding Evidence of Cardiovascular Protection across Broad Spectrum of Patients

Earlier Treatment Intervention in Heart Failure Patients Results in Improved Outcomes

Large PIONEER-HF Trial Validates Safety and Benefits of In-Hospital Initiation of Therapeutic Treatment

DECLARE-TIMI 58: Latest SGLT2 Cardiovascular Trial Supports Benefits beyond Glucose Control

Latebreaker Trial Shows Heart Failure Recovery Is Remission and Not a Cure